id,key,key_class,(days),(hours),(months),(years),cell,genotype/variation,line,point,post,sample,source,state,status,timepoint,type
0,disease-free survival (dfs),disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
8,disease relapse (event),disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
9,disease_free_survival_event,disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
10,disease_free_survival_years,disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
12,disease_severity,disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
15,code disease-specific survival,disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
19,age at disease onset,disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
20,disease free interval (months),disease,0,0,1.02459,0,0,0,0,0,0,0,0,0,0,0,0
24,disease extension,disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
27,disease progression,disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
28,disease stage,disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
30,disease severity/outcome,disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
32,diseasestatus,disease,0,0,0,0,0,0,0,0,0,0,0,0,1.02158,0,0
39,disease course,disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
47,disease progression status,disease,0,0,0,0,0,0,0,0,0,0,0,0,1.02158,0,0
48,disease state (phenotype),disease,0,0,0,0,0,0,0,0,0,0,0,1.01861,0,0,1.09279
50,disease state,disease,0,0,0,0,0,0,0,0,0,0,0,1.01861,0,0,0
51,disease model,disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
55,disease/treatment status,disease,0,0,0,0,0,0,0,0,0,0,0,0,1.02158,0,0
59,twin's disease state,disease,0,0,0,0,0,0,0,0,0,0,0,1.01861,0,0,0
61,lyme disease stage,disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
62,dead of disease,disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
64,advanced disease stage,disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
69,advanced disease state,disease,0,0,0,0,0,0,0,0,0,0,0,1.01861,0,0,0
75,hiv disease status,disease,0,0,0,0,0,0,0,0,0,0,0,0,1.02158,0,0
77,meibomian gland disease state,disease,0,0,0,0,0,0,0,0,0,0,0,1.01861,0,0,0
82,stage of disease (inss),disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
252,host gender,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
360,age at metastases,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
378,ageyear,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
463,160!!!,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
567,vitis (41528 population) - age,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
632,background mouse strain,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
739,strain/genotype,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.09279
760,cell type [c],no disease,0,0,0,0,1.25381,0,0,0,0,0,0,0,0,0,1.09279
789,time after treatment,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
851,ligand treatment,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
915,cardioglycoside treatment,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1030,host cell line,no disease,0,0,0,0,1.25381,0,1.14386,0,0,0,0,0,0,0,0
1172,genotype/background,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.09279
1199,genotype variation,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.09279
1210,brca genotype,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.09279
1272,cell harvest time,no disease,0,0,0,0,1.25381,0,0,0,0,0,0,0,0,0,0
1276,mnase digestion time,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1460,time (d),no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1579,time before sampling,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1580,time to survival,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
1587,time post-infection,no disease,0,0,0,0,0,0,0,0,1.01579,0,0,0,0,0,0
1644,time f/u,no disease,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
